In heterogeneous catalysis, the catalyst is in a different phase from the reactants. HPLC of Formula: C5H7N3, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 18591-82-7, name is 6-Methylpyridazin-3-amine. In an article，Which mentioned a new discovery about 18591-82-7
A set of 5,6-fused bicyclic heteroaromatic scaffolds were investigated for their in vitro anti-tubercular activity versus replicating and non-replicating strains of Mycobacterium tuberculosis (Mtb) in an attempt to find an alternative scaffold to the imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrimidines that were previously shown to have potent activity against replicating and drug resistant Mtb. The five new bicyclic heteroaromatic scaffolds explored in this study include a 2,6-dimethylimidazo[1,2-b]pyridazine-3-carboxamide (7), a 2,6-dimethyl-1H-indole-3-carboxamide (8), a 6-methyl-1H-indazole-3-carboxamide (9), a 7-methyl-[1,2,4]triazolo[4,3-a]pyridine-3-carboxamide (10), and a 5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide (11). Additionally, imidazo[1,2-a]pyridines isomers (2 and 12) and a homologous imidazo[1,2-a] pyrimidine isomer (6) were prepared and compared. Compounds 2 and 6 were found to be the most potent against H37Rv Mtb (MIC’s of 0.1 muM and 1.3 muM) and were inactive (MIC >128 muM) against Staphylococcus aureus, Escherichia coli and Candida albicans. Against other non-tubercular mycobacteria strains, compounds 2 and 6 had activity against Mycobacterium avium (16 and 122 muM, respectively), Mycobacterium kansasii (4 and 19 muM, respectively), Mycobacterium bovis BCG (1 and 8 muM, respectively) while all the other scaffolds were inactive (>128 muM).
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 18591-82-7, help many people in the next few years.Safety of 6-Methylpyridazin-3-amine
Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N240 – PubChem